Literature DB >> 5121213

Bioavailability of digoxin.

T G Vitti, D Banes, T E Byers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5121213     DOI： 10.1056/NEJM197112162852512

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  A history of biopharmaceutics in the Food and Drug Administration 1968-1993.

Authors:  Jerome Philip Skelly
Journal:  AAPS J       Date:  2009-11-20       Impact factor: 4.009

2.  Dose of digoxin and age of child.

Authors:  B S Doshi; K C Vijayaraghavan; D Ajit; B L Chauhan; Y K Amdekar; R D Kulkarni
Journal:  Indian J Pediatr       Date:  1987 Mar-Apr       Impact factor: 1.967

3.  Serum digoxin concentration and diagnosis of digitalis toxicity. Current concepts.

Authors:  T H Lee; T W Smith
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

4.  Re-examining digoxin bioavailability after half a century: Time for changes in the bioavailability concepts.

Authors:  Athanasios A Tsekouras; Panos Macheras
Journal:  Pharm Res       Date:  2021-10-18       Impact factor: 4.200

5.  Biological availability of digoxin from Lanoxin produced in the United Kingdom.

Authors:  B F Johnson; A S Fowle; S Lader; J Fox; A D Munro-Faure
Journal:  Br Med J       Date:  1973-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.